Skip to main content
See every side of every news story
Published loading...Updated

Oral brain-targeted MEAI shows fat loss in mice, pitched as GLP-1 alternative

Summary by stocktitan.net
Pre-clinical MEAI cut weight ~20% and preserved muscle in mice as Clearmind pursues obesity patents, intranasal delivery and an FDA-approved AUD trial.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Thursday, February 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal